{"id":"https://genegraph.clinicalgenome.org/r/fde7dd42-8b89-4205-b5ea-0e398b769e98v1.0","type":"EvidenceStrengthAssertion","dc:description":"*FGFR2* was first reported in relation to autosomal dominant LADD syndrome in 2006 (Rohmann E et al., PMID: 22387015). 6 variants (missense, deletion) that have been reported in 8 probands in 3 publications and 2 ClinVar entries (PMIDs:16501574,28043400, 32715658,1 SCV000781492.1 (VCV000547379.1), SCV000781491.1 (VCV000547378.1)) are included in this curation. The mechanism of pathogenicity appears to be dominant negative. This gene-disease association is also supported by functional alteration and animal model evidence. (PMIDs: 30253032,18056630, 17682060). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Craniofacial Malformations Gene Expert Panel on the meeting date June 16, 2022 (SOP Version 8)","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/fde7dd42-8b89-4205-b5ea-0e398b769e98","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2022-06-16T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2025-06-09T22:18:59.267Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfb7d934-f6a8-49d5-abc4-d060de888b8d","type":"EvidenceLine","dc:description":"Downgraded due to insufficient evidence \n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1b1612b-5207-4d28-9e91-df254dd5c854","type":"Finding","dc:description":"Correlates with reduced auditory function in mutant mice. Suggests genetic conductive hearing loss in LADD syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30253032","rdfs:label":"Conditional knockout of FGFR2 in neural crest cells of mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/313f72ef-30cb-4ff9-9e90-31c88bb2beae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9532e91-5ec9-41eb-87b5-47a3df430ea3","type":"FunctionalAlteration","dc:description":"A628T-FGFR2 failed to undergo autophosphorylation, greatly impaired FGFR2 catalytic activity. Fluorescence titration found that ATP-binding was normal in A628T-FGFR2.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18056630","rdfs:label":"In vitro assay performed with WT-FGFR2 or A628T-FGFR2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e9136ffc-cb9f-4703-80f1-c3152e11dd8a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d4671b4-c8bf-4dfb-bdf6-43e7341ee991","type":"FunctionalAlteration","dc:description":" Stimulated with FGF10 then immunoprecipitation assay testing tyrosine autophosphorylation â†’ very weak phosphorylation, (R649S showed highest activity and A628T showed weakest activity). The variants failed to stimulate tyrosine phosphorylation of two well-characterized FGFR substrates, FRS2 and Shc. Downstream MAPK activation barely detectable. Contrasts with robust phosphorylation/activation in K641R-FGFR2. Also showed dominant negative effect with heterodimers formed by variant protein and WT protein.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17682060","rdfs:label":"A648T-, R649S-, and A628T-FGFR2 tyrosine kinase activity"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c4f916e-4e1e-448b-97dd-1d68091c8669","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c4f916e-4e1e-448b-97dd-1d68091c8669_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","allele":{"id":"https://genegraph.clinicalgenome.org/r/abccb5d2-0643-46af-bbc2-3f0e38b8c00e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000141.5(FGFR2):c.1947_1949del (p.Arg649_Asp650delinsSer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575519"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e9dca044-7b44-49cb-b8ea-31e89ab0fcc3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9dca044-7b44-49cb-b8ea-31e89ab0fcc3_variant_evidence_item","type":"VariantObservation","dc:source":{"id":"https://identifiers.org/clinvar.submission:SCV000781491.1","type":"dc:BibliographicResource","dc:creator":"Center for Human Genetics, Inc, Center for Human Genetics, Inc","dc:date":"2018-07-09","dc:title":"NM_000141.5(FGFR2):c.1477G>T (p.Gly493Trp)","about":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/547378"}},"allele":{"id":"https://genegraph.clinicalgenome.org/r/68ed4d18-eb68-4719-a1a9-53fad90dc39c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000141.5(FGFR2):c.1477G>T (p.Gly493Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA378323223"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cce7558c-ec9c-4d2a-bff5-2c1646de955f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b26366e-2c6a-4623-aa64-24de2e327878_proband_segregation","type":"FamilyCosegregation","dc:description":"Authors report combined LOD score of 3.61 (estimation using ClinGen framework is 3.3). All diagnosed with LADD syndrome (specific phenotypes on next slide), but craniosynostosis and short stature were not found in any of the affected individuals. Sequencing of entire FGFR2 gene in affected individuals, genotyping of specific variant in unaffected individuals (confirm absence). Haplotype analysis to determine variant arose independently in LADD-Nij and LADD-Le families.\nCan add additional points for phenotypic specificity, if any of images on next slide qualify.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Le family, England","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/2b26366e-2c6a-4623-aa64-24de2e327878","type":"Family","rdfs:label":"LADD-Le family, England","member":{"id":"https://genegraph.clinicalgenome.org/r/a098f10f-a701-46c2-ac4a-6624f8bc2cd3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Le family, England","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e44689b-99d2-41e3-aaeb-cd6f75cc8279","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000141.5(FGFR2):c.1942G>A (p.Ala648Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122998"}},"firstTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0bc5180e-0b24-45df-8b05-034e0c627218_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e44689b-99d2-41e3-aaeb-cd6f75cc8279"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a098f10f-a701-46c2-ac4a-6624f8bc2cd3"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/72fe8226-dbff-4f4b-99ed-2d8b8ebf1b0e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Nij family, The Netherlands","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/72fe8226-dbff-4f4b-99ed-2d8b8ebf1b0e","type":"Family","rdfs:label":"LADD-Nij family, The Netherlands","member":{"id":"https://genegraph.clinicalgenome.org/r/5dcf3686-920c-408a-8481-5defe907e890","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Nij family, The Netherlands Proband ","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e44689b-99d2-41e3-aaeb-cd6f75cc8279"},"firstTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c4c682ba-8ae7-42de-bfab-ec8e5ae95de3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e44689b-99d2-41e3-aaeb-cd6f75cc8279"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/5dcf3686-920c-408a-8481-5defe907e890"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/da76a376-3c5d-40b3-a8ea-101725ba3dbd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Ist family, Turkey","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/da76a376-3c5d-40b3-a8ea-101725ba3dbd","type":"Family","rdfs:label":"LADD-Ist family, Turkey","member":{"id":"https://genegraph.clinicalgenome.org/r/e9a746d1-0142-40e5-b037-3978f160f182","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","rdfs:label":"LADD-Ist family, Turkey","allele":{"id":"https://genegraph.clinicalgenome.org/r/abccb5d2-0643-46af-bbc2-3f0e38b8c00e"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2c4f916e-4e1e-448b-97dd-1d68091c8669_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e9a746d1-0142-40e5-b037-3978f160f182"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/825c3029-c967-404a-b063-b946d6749d8e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/825c3029-c967-404a-b063-b946d6749d8e_variant_evidence_item","type":"VariantObservation","dc:source":{"id":"https://identifiers.org/clinvar.submission:SCV000781492.1","type":"dc:BibliographicResource","dc:creator":"Center for Human Genetics, Inc, Center for Human Genetics, Inc","dc:date":"2018-07-09","dc:title":"NM_000141.5(FGFR2):c.2021C>T (p.Ala674Val)","about":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/547379"}},"allele":{"id":"https://genegraph.clinicalgenome.org/r/59d10618-a18a-4c03-a216-9d5bab5a2238","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000141.5(FGFR2):c.2021C>T (p.Ala674Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA378313216"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0bc5180e-0b24-45df-8b05-034e0c627218","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bc5180e-0b24-45df-8b05-034e0c627218_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7cdbfa5c-dbeb-4780-8e7a-fa0f3c218ed1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cdbfa5c-dbeb-4780-8e7a-fa0f3c218ed1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501574","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e44689b-99d2-41e3-aaeb-cd6f75cc8279"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c1869e09-085b-4eeb-8c56-60fee3547cf9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1869e09-085b-4eeb-8c56-60fee3547cf9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32715658","allele":{"id":"https://genegraph.clinicalgenome.org/r/cad7978d-f364-4df0-8f2e-40a657fbf447","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000141.5(FGFR2):c.1544C>T (p.Ala515Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA378322753"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c4c682ba-8ae7-42de-bfab-ec8e5ae95de3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4c682ba-8ae7-42de-bfab-ec8e5ae95de3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fec5a56b-2002-49c3-be2f-27e538fbaeb8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fec5a56b-2002-49c3-be2f-27e538fbaeb8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28043400","allele":{"id":"https://genegraph.clinicalgenome.org/r/cad7978d-f364-4df0-8f2e-40a657fbf447"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.2}],"evidenceStrength":"Limited","sequence":10559,"specifiedBy":"GeneValidityCriteria8","strengthScore":3.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/X0_kAv5OAg8","type":"GeneValidityProposition","disease":"obo:MONDO_0007872","gene":"hgnc:3689","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cce7558c-ec9c-4d2a-bff5-2c1646de955f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}